22 May 2013
Keywords: fda, tee, gives, ok, seragen, ontak, advisory
Article | 04 June 1998
An advisory committee to the US Food and Drug Administration hasunanimously backed Seragen's Ontak (denileukin diftitox) for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.